Biogen Background Information (This description is provided by the company.) At Biogen, mission is clear: company is pioneer in neuroscience. Biogen discovers, develops and delivers worldwide ...
Fintel reports that on November 18, 2024, Needham downgraded their outlook for Biogen (NasdaqGS:BIIB) from Buy to Hold.
Biogen Background Information (This description is provided by the company.) At Biogen, mission is clear: company is pioneer in neuroscience. Biogen discovers, develops and delivers worldwide ...